Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice
Science Advances · 2023
DOI: 10.1126/sciadv.adh2264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Madeline M Schwarz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Rift Valley Fever, Rift Valley fever virus. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Rift Valley fever virus (RVFV) is an emerging arbovirus found in Africa. While RVFV is pantropic and infects many cells and tissues, viral replication and necrosis within the liver play a critical role in mediating severe disease. The low-density lipoprotein receptor–related protein 1 (Lrp1) is a recently identified host factor for cellular entry and infection by RVFV. The biological significance of Lrp1, including its role in hepatic disease in vivo, however, remains to be determined. Because Lrp1 has a high expression level in hepatocytes, we developed a mouse model in which Lrp1 is specifically deleted in hepatocytes to test how the absence of liver Lrp1 expression affects RVF pathogenesis. Mice lacking Lrp1 expression in hepatocytes showed minimal RVFV replication in the liver, longer time to death, and altered clinical signs toward neurological disease. In contrast, RVFV infection levels in other tissues showed no difference between the two genotypes. Therefore, Lrp1 is essential for RVF hepatic disease in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
- Transgenic, Knockout and Micro-Injection Core, Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
- Genome Engineering & Stem Cell Center, Department of Genetics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
- Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
ORCID-Profile: Madeline M Schwarz, Safder S Ganaie, Annie Feng, Griffin Brown, Tenzin Yangdon, J Michael White, Cynthia M McMillen, Rachael E Rush, Kaleigh A Connors, Xiaoxia Cui, Daisy W Leung, Takeshi Egawa, Gaya K Amarasinghe, Amy L Hartman
Förderung
- NIAID NIH HHS
Zitieren
APA
Schwarz, M. M., Ganaie, S. S., Feng, A., Brown, G., Yangdon, T., White, J. M., Hoehl, R. M., McMillen, C. M., Rush, R. E., Connors, K. A., Cui, X., Leung, D. W., Egawa, T., Amarasinghe, G. K., & Hartman, A. L. (2023). Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice. Science Advances. https://doi.org/10.1126/sciadv.adh2264
Vancouver
Schwarz MM, Ganaie SS, Feng A, Brown G, Yangdon T, White JM, et al. Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice. Science Advances. 2023. doi:10.1126/sciadv.adh2264
BibTeX
@article{Schwarz2023,
author = {Schwarz, Madeline M and Ganaie, Safder S and Feng, Annie and Brown, Griffin and Yangdon, Tenzin and White, J Michael and Hoehl, Ryan M and McMillen, Cynthia M and Rush, Rachael E and Connors, Kaleigh A and Cui, Xiaoxia and Leung, Daisy W and Egawa, Takeshi and Amarasinghe, Gaya K and Hartman, Amy L},
title = {Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adh2264}
}
EUVIMED